Genomic Vision 

0
0
+€0,00+0% 00:00 Dnes

Statistiky

Denní maximum
-
Denní minimum
-
52týdenní maximum
-
52týdenní minimum
-
Objem obchodů
-
Prům. objem
-
Tržní kap.
0
Poměr P/E
-
Dividendový výnos
-
Dividenda
-

Konkurenti

Tento seznam je analýza založená na nedávných tržních událostech. Nejde o investiční doporučení.

O aplikaci

Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides CombHeliX FSHD probes for the diagnosis of facioscapulohumeral dystrophy; FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur; and development agreement with Integrated Technologies Ltd for the design and development of a high-throughput scanning instrument for molecular combing assays. The company was founded in 2004 and is headquartered in Bagneux, France.
Zobrazit více
CEO
Mr. Aaron Bensimon
Zaměstnanci
27
Země
Francie
ISIN
FR0011799907
WKN
000A110TM

Zalistování

0 komentářů

Poděl se o svůj názor

Časté dotazy

Jaký ticker má akcie společnosti Genomic Vision?▼
Ticker akcie se může lišit podle burzy. Například na burze Boerse Muenchen se akcie společnosti Genomic Vision obchodují pod tickerem G09.MU.
Kolik má Genomic Vision zaměstnanců?▼
Ke dni 2. listopadu 2026 má společnost 27 zaměstnanců.
Do jakého sektoru patří Genomic Vision?▼
Genomic Vision působí v sektoru Health & Wellness.
Kdy společnost Genomic Vision provedla split akcií?▼
Společnost Genomic Vision v poslední době neprovedla žádný split akcií.
Kde má Genomic Vision sídlo?▼
Genomic Vision má sídlo ve městě Bagneux, Francie.